Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the …
F Kamangar, GM Dores, WF Anderson - Journal of clinical oncology, 2006 - ascopubs.org
Efforts to reduce global cancer disparities begin with an understanding of geographic
patterns in cancer incidence, mortality, and prevalence. Using the GLOBOCAN (2002) and …
patterns in cancer incidence, mortality, and prevalence. Using the GLOBOCAN (2002) and …
Portfolio theory: as I still see it
HM Markowitz - Annu. Rev. Financ. Econ., 2010 - annualreviews.org
This essay summarizes my views on (a) the foundations of portfolio theory and its
applications to current issues, such as the choice of criteria for practical risk-return analysis …
applications to current issues, such as the choice of criteria for practical risk-return analysis …
[HTML][HTML] Case–control study of human papillomavirus and oropharyngeal cancer
Background Substantial molecular evidence suggests a role for human papillomavirus
(HPV) in the pathogenesis of oropharyngeal squamous-cell carcinoma, but epidemiologic …
(HPV) in the pathogenesis of oropharyngeal squamous-cell carcinoma, but epidemiologic …
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
S De Sanjosé, M Diaz, X Castellsagué… - The Lancet infectious …, 2007 - thelancet.com
We set out to estimate the age and genotype-specific prevalence of cervical human
papillomavirus (HPV) DNA in women with normal cervical cytology worldwide by meta …
papillomavirus (HPV) DNA in women with normal cervical cytology worldwide by meta …
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
SM Garland, M Hernandez-Avila… - … England Journal of …, 2007 - Mass Medical Soc
Background A phase 3 trial was conducted to evaluate the efficacy of a prophylactic
quadrivalent vaccine in preventing anogenital diseases associated with human …
quadrivalent vaccine in preventing anogenital diseases associated with human …
[HTML][HTML] Prevalence of HPV infection among females in the United States
EF Dunne, ER Unger, M Sternberg, G McQuillan… - Jama, 2007 - jamanetwork.com
Context Human papillomavirus (HPV) infection is estimated to be the most common sexually
transmitted infection. Baseline population prevalence data for HPV infection in the United …
transmitted infection. Baseline population prevalence data for HPV infection in the United …
Molecular biology of human papillomavirus infection and cervical cancer
J Doorbar - Clinical science, 2006 - portlandpress.com
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging
from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types …
from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types …
Association between cervical microbiota and HPV: could this be the key to complete cervical cancer eradication?
E Cascardi, G Cazzato, A Daniele, E Silvestris… - Biology, 2022 - mdpi.com
Simple Summary The microbiota can modulate immune responses and modify the
physiology of the human organism, thereby increasing infective risks and a neoplastic …
physiology of the human organism, thereby increasing infective risks and a neoplastic …
The epidemiology of human papillomavirus infections
JG Baseman, LA Koutsky - Journal of clinical virology, 2005 - Elsevier
Infection with oncogenic human papillomavirus (HPV) types is a necessary cause of cervical
cancer, the second most frequently occurring cancer in women worldwide. Rates of …
cancer, the second most frequently occurring cancer in women worldwide. Rates of …
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Background Vaccination against the most common oncogenic human papillomavirus (HPV)
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …